(Q45802398)

English

Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor

scientific article published on March 1, 1981

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor (English)

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

viral antibodies

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6260386

10 September 2023

Cell Migration Inhibition

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6260386

10 September 2023

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

author name string

R. Szigeti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6260386

10 September 2023

J. Luka

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6260386

10 September 2023

G. Klein

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6260386

10 September 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6260386

10 September 2023

publication date

1 March 1981

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

full work available at URL

https://api.elsevier.com/content/article/PII:0008874981902203?httpAccept=text/xml

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

https://api.elsevier.com/content/article/PII:0008874981902203?httpAccept=text/plain

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Cellular Immunology

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

58

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

269-276

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis

1

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Epstein-Barr herpesvirus infection: Inhibition by immunologically induced mediators with interferon-like properties

2

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Cell mediated immunity during infectious mono-nucleosis to epstein-barr virus associated antigens

3

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Abrogation of Cell-Mediated Immunity by a Serum Blocking Factor Isolated from Patients with Infectious Mononucleosis

4

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Leukocyte Migration Inhibition with Epstein-Barr Virus Negative and Positive Cell Extracts

5

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV

8

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

9

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

12

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay

14

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay.

15

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Effect of phytohaemagglutinin in the leucocyte migration inhibition test as a measure of cell-mediated immunity

16

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

17

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines

19

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Identity of the soluble EBV-associated antigens of human lymphoid cell lines

22

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis

23

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Tumour-specific transplantation antigen from SV40 transformed cells binds to DNA

24

1 reference

10.1016/0008-8749(81)90220-3

https://api.crossref.org/works/10.1016/0008-8749(81)90220-3

10 September 2023

Identifiers

10.1016/0008-8749(81)90220-3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/6260386

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45802398&oldid=1971394458"